1708279437
ACRO's Good Clinical Podcast

Advertise on podcast: ACRO's Good Clinical Podcast

Rating
★★★★★
4.7
from
7 reviews
This podcast has
37 episodes
Language
English
Publisher
ACRO
Explicit
No
Date created
2023/09/20
Latest episode
2026/11/10
Average duration
34 min.
Release period
37 days

Description

ACRO’s Good Clinical Podcast dives into topics vital to driving innovation in clinical research, from AI and other cutting-edge technology to regulatory topics that impact clinical trials around the world. ACRO's Sophia McLeod is joined by leaders from across the drug development industry to discuss the latest trends and what direction the industry must head to continue improving trials for patients 

Unlock ACRO's Good Clinical Podcast podcast Email contact info,
Listeners & Audience details

Email contact information

Direct podcast contact details

Listeners

Audience numbers & engagement insights

Audience details

Podcast Insights

Podcast episodes

Check latest episodes from ACRO's Good Clinical Podcast podcast


S5: E5 Beyond Complexity: Designing Better Oncology Clinical Trials
2026/11/10
As precision medicine advances and oncology therapies become increasingly complex, are clinical trials evolving fast enough to keep pace and are we making them too burdensome for the patients they are designed to serve?In this episode of ACRO’s Good Clinical Podcast, host Sophia McLeod is joined by Angela Fix and David Cohan to explore how the industry can rethink oncology clinical trial design, improve patient access, and translate scientific advances into more effective and efficient research.The conversation examines the role of artificial intelligence in patient identification, protocol design, and data analysis; the potential of decentralized and hybrid approaches to bring trials closer to patients; and the importance of simplifying trial requirements while maintaining patient safety and data quality. The discussion also highlights persistent operational challenges, including biomarker-driven enrollment and the manufacturing and supply chain demands of increasingly complex therapies.Looking ahead, the guests consider how AI, broader care networks, and emerging treatments such as tumor vaccines could reshape oncology clinical trials over the next five years.
S5: E4 Cybersecurity is Patient Safety: Protecting the Future of Clinical Trials
2026/11/03
As clinical trials become increasingly digital and interconnected, cybersecurity is critical to protecting data integrity, maintaining trial continuity, and safeguarding patient safety. In this episode of ACRO’s Good Clinical Podcast, Sophia McLeod is joined by cybersecurity leaders Nelly Nauman (Parexel), Mick Ryan (ICON), and Charley Newberry (Syneos) to explore the evolving cyber threat landscape facing clinical research.In this episode, they discuss emerging cybersecurity risks, including AI, ransomware, third-party vulnerabilities, and decentralized trials. Speakers shared their experience and strategies for strengthening cyber resilience, protecting data integrity, and fostering industry collaboration to safeguard clinical research.They also shared perspectives on emerging security challenges and why cybersecurity, data trust, and patient safety must be built into clinical trial design from day one.
S5: E3 AI Agents at Work: Connecting the Clinical Trial Ecosystem
2026/10/27
Collaboration is at the core of connecting the clinical research ecosystem without adding to the technology burden for sites. The ongoing partnership between Advarra and ICON offers a practical example of what this can look like.In Good Clinical Podcast Season 5, Episode 3, Mike Eckrote (Advarra) and Travis Caudill (ICON) discuss how their collaboration is helping move toward an ecosystem where organizations and sites can continue using the tools that best meet their needs, while enabling information to flow seamlessly across systems and organizational boundaries.They explore the potential to reduce administrative complexity, improve interoperability, strengthen site efficiency, and keep humans at the center of critical decisions, ultimately creating more time and capacity for what matters most: patients.
S5: E2 The Future of Early-Stage Trials: Speed, Safety, and Innovation
2026/10/20
What does the future of early-stage clinical research look like?In this episode, experts from clinical operations, IRB/regulatory oversight, and technology/policy — Amy Roach (Parexel), Bert Wilkins (WCG), and Jackie Ward (Veeva) — explore the evolving landscape of early-stage clinical trials in the U.S. From regulatory modernization and global competitiveness to interoperability, participant access, and increasingly complex trial designs, the discussion centers on how the U.S. can improve speed, efficiency, and predictability while preserving safety, rigor, and quality.
S5: E1 The Journey of RBQM & AI for Trial Monitoring: Where We Are
2026/10/13
AI is transforming trial monitoring from a reactive process into a proactive, risk-driven discipline. In this episode, ACRO RBQM Working Group members Cris McDavid (Parexel), Shailesh Madel (ICON), and Linda Phillips (IQVIA), come together to examine how artificial intelligence and machine learning can help identify risks and signals faster while humans maintain accountability and oversight.From accelerating the identification of Critical-to-Quality (CtQ) factors and enhancing centralized monitoring to addressing concerns around pushing humans out of the loop, the discussion highlights both the challenges and opportunities ahead. With insights on how AI is already being leveraged to increase operational efficiencies while balancing patient safety and data integrity, this episode offers a glimpse into the future of centralized monitoring.
S4: E8 Moving from Awareness to Execution in Trial Representation
2026/06/22
In this episode of ACRO's GCP, Tinaya Gray (Executive Director, Site Engagement & PACE at ICON plc), Jan Hewett (SVP, FDA Regulatory Advisor at Advarra), and Jackie Kent (Independent Advisor) unpack the work of ACRO's dive team on representative, generalizable clinical trial data at the 2025 Innovation Network Gathering. Together, they explore why clinical trial populations still fail to reflect real-world patients, and what's been holding the industry back from meaningful progress.The conversation goes beyond identifying the problem. The group shares how a diverse set of stakeholders were able to align around practical, implementable solutions. They also discuss how industry can pilot new approaches, engage broader stakeholders, and turn promising ideas into standard practice. This episode offers a candid and solutions-oriented look at how to generate clinical data that truly supports better decision-making for all patients.
S4: E7 Advancing Sustainability Through Smarter Clinical Trial Design
2026/06/15
Artificial intelligence is reshaping clinical research, but its impact extends far beyond automation. In this episode of ACRO’s Good Clinical Podcast, host Sophia McLeod is joined by Paulo Limgenco (VP, Business Operations at YPrime) and Michael Tucker (VP, Patient Experience - Commercial at Medidata) to explore how AI and digital technologies are helping the industry build more sustainable, efficient, and patient-centered clinical trials.From protocol optimization and site selection to localization and decentralized trial models, the conversation examines how AI can reduce operational burdens, minimize waste, and expand access to research opportunities for underrepresented populations. The discussion also highlights the importance of responsible AI adoption, including strong governance frameworks, data stewardship, and human oversight.Tune in for an insightful conversation on how the industry is balancing innovation and responsibility while working toward a future where clinical trials are more efficient, inclusive, and sustainable for patients, sites, sponsors, and communities worldwide.
S4: E6 Collaborating to Drive Global Progress in Clinical Research
2026/06/08
What does it take to run successful clinical trials across borders? Tune in as Chris Boone (Group VP, Research, Health & Life Sciences at Oracle) and Alicia Baker McDowell (VP & Head of Global Regulatory Strategy at Fortrea) explore the shift from transactional outsourcing to truly co-created partnerships.They discuss how sponsors, CROs, and tech partners are redefining collaboration, tackling data fragmentation, and striking the right balance between global consistency and local execution to deliver more effective clinical trials worldwide.
S4: E5 Advancing Rare Disease Research Through AI Innovation and Patient Trust
2026/06/01
Artificial intelligence is rapidly reshaping the landscape of rare disease research -- but how close are we to realizing its full potential? In this episode, Tanya Binette (Director of Therapeutic Expertise, Rare Disease at ICON plc) and Roz Round (SVP of Operational Strategy, Patient and Site Engagement at Precision for Medicine) explore how AI is being applied across the rare disease clinical trial lifecycle, from drug discovery and protocol design to patient identification and engagement.The discussion highlights both the promise and complexity of using AI in a research space defined by small patient populations, fragmented data, and unique ethical considerations. Guests emphasize the importance of patient trust, regulatory alignment, and responsible innovation, while also identifying opportunities to accelerate trials, improve access, and empower patients through AI-enabled tools.
S4: E4 Improving Site Feasibility Through Better Data Collaboration and Timing
2026/05/26
Site feasibility remains a critical yet complex component of clinical trial startup. In this episode, listen as Andrea Bastek (VP, Market Strategy at Florence Healthcare), Christine Senn (SVP, Site-Sponsor Innovation at Advarra), and Ashley Davidson (SVP, Head of Product at Advarra) unpack the persistent challenges in feasibility -- from manual, time-intensive processes and data trust gaps to misaligned timelines and limited transparency between stakeholders.The conversation explores how collaboration, smarter process design, and emerging technologies like AI and real-time data integration can reduce burden on sites and improve study startup timelines. Guests also share practical recommendations, including simplifying CDA processes, improving communication between sponsors and sites, and leveraging data more effectively to move forward toward a more efficient and connected feasibility model.Resources:- Advarra CDA Template - Advarra Site ID Feasibility Solution- Paper from Florence Healthcare's Site Enablement League
S4: E3 Evolving Patient Engagement from Transactional to Transformational
2026/05/18
What does "patient-centricity" actually look like in practice, and why does it still fall short? In this episode, Stacy Hurt (Chief Patient Officer at Parexel) and Alicia Staley (Chief Patient Officer at Medidata) bring both lived experience and industry insight to a powerful discussion on the gaps between intention and reality in clinical research. They unpack the emotional and logistical challenges patients face, from navigating fragmented systems to feeling dismissed by well-meaning but unhelpful messaging. The discussion highlights the need for systemic thinking, stronger partnerships with advocacy communities, and greater adoption of patient leadership roles. With real-world examples and a forward-looking perspective, this episode offers a roadmap for turning patient-centricity into tangible change.
S4: E2 How Small Grants Drive Big Changes Through Site-Led Innovation
2026/05/11
What happens when clinical trial sites are given the resources and autonomy to determine precisely what their site needs to be successful? In this episode, participants from the ACRO Site Grants Program share how targeted funding helped them tackle real-world barriers to clinical trial access and diversity. From community-based outreach and patient education, to internal infrastructure and staffing, these sites implemented tailored solutions designed to meet the unique needs of their communities. Along the way, they encountered challenges, adapted their approaches, and uncovered valuable lessons about trust-building, flexibility, and long-term engagement.This conversation highlights how even small investments can drive meaningful change at the site level, and what the broader industry can learn from these experiences.
S4: E1 Building a Global AI Framework for Clinical Trials
2026/05/04
Artificial intelligence is reshaping every stage of drug development, but unlocking its full potential requires more than technology alone. In this episode, Clay Alspach (Executive Director, ACRO) Raja Shankar (VP of Machine Learning at IQVIA), and Andrew Mackinnon (SVP & Executive General Manager at Medable) come together to examine how policy, regulation, and global collaboration will shape the future of AI in clinical trials.From breaking down data silos to addressing regulatory uncertainty and enabling a “try first” mindset, the discussion highlights both the opportunities and the complexities ahead. With insights on patient impact, site experience, and the next wave of innovation, this episode offers a roadmap for advancing AI in a way that is both responsible and transformative.
S3: E10 Survey Says: Trends in Risk-Based Monitoring and Beyond
2025/06/23
LINK TO ACRO'S RBQM SUMMARY REPORT: https://www.acrohealth.org/rbqm-summary-report/In this episode, ACRO RBQM Working Group members Lauren Garson (Veeva), Cris McDavid (Parexel), and Jennifer Stewart (Premier Research) joined ACRO’s Good Clinical Podcast to discuss key takeaways from ACRO's annual RBM/RBQM Landscape Survey. Since 2019, ACRO's RBQM survey has dug into trial-level data on industry adoption of RBM and RBQM components. Informed by conversations with FDA, the aim of the survey is to evaluate ACRO member companies’ adoption of risk-based monitoring to better understand how the larger framework of risk-based quality management (RBQM) are being adopted across the clinical trial industry.
S3: E9 Granting Access to Research: Lessons from ACRO’s Site Grant Program
2025/06/16
In 2024, ACRO announced its D&I Site Resource Grants Program. Designed to support an innovative 12-month pilot project, the site resource grants act as a platform to incubate innovative strategies for improving representative enrollment in clinical research.  On this episode, site grantee representatives Dr. Ammara Mushtaq, MD (Brooklyn Clinical Research), Dr. Lovie Negrin, APRN (Randomize Now), and Sandra Carmona Torres, BSN (K2 Medical Research) join the podcast to discuss the lessons learned through implementing their pilot projects so far. They dive deeper into how sites can address barriers to participation, the need for consistent investment in building trust and engaging local community members, and the state of clinical research from a site perspective.

Podcast reviews

Read ACRO's Good Clinical Podcast podcast reviews


4.7 out of 5
7 reviews
★★★★★
avapo 2023/10/17
Superb!
ACRO is producing one of its kind content with GCP. A must listen.
check all reviews on apple podcasts

Podcast sponsorship advertising

Start advertising on ACRO's Good Clinical Podcast relevant audience podcasts


What do you want to promote?